Related by context. Frequent words. (Click for all words.) 63 heavily pretreated 60 forodesine 59 heavily pretreated patients 59 recurrent glioblastoma 58 prospectively defined 57 sustained virological response 57 phase Ib 56 HER2 positive metastatic breast 56 pharmacokinetic parameters 56 % CI #.#-#.# [003] 56 mRCC 56 superficial bladder cancer 55 multiple myeloma MM 55 colorectal carcinoma 55 sustained virologic response 55 HIV uninfected 55 coinfected 55 mcg dose 55 neoadjuvant 55 virologic 55 Secondary endpoints included 55 HNSCC 55 pancreatic adenocarcinoma 54 FOLFOX4 54 metastatic castration resistant 54 biochemical recurrence 54 virologic failure 54 median CD4 54 androgen independent 54 undetectable HCV RNA 54 administered subcutaneously 54 Pivotal Phase III 54 cervical intraepithelial neoplasia 54 enzastaurin 54 tanespimycin 54 Secondary endpoints include 54 axitinib 53 complete cytogenetic 53 refractory chronic lymphocytic 53 HCV infected 53 virological failure 53 ILLUMINATE 53 % CI #.#-#.# [007] 53 Median survival 53 seroprotection 53 pertuzumab 53 advanced adenomas 53 bendamustine 53 KRAS wild 53 mg QD 53 pharmacodynamic effects 53 RRMS patients 53 evaluable 53 androgen deprivation 53 virologic response 53 glufosfamide 53 statistically significant p = 52 nab paclitaxel 52 Cloretazine R VNP#M 52 Pivotal Phase 52 CMV disease 52 plus methotrexate 52 plus dexamethasone 52 T2DM 52 EBRT 52 acute GVHD 52 HER2 negative 52 phase IIa clinical 52 Secondary endpoints 52 elotuzumab 52 CMV infection 52 ascending doses 52 multicenter Phase 52 prolongs survival 52 peginterferon alfa 52 adjuvant radiation 52 Initiate Phase 52 metastatic renal cell carcinoma 52 TOLAMBA 52 haematological 52 chlorambucil 52 gastrointestinal stromal tumors 52 mCRC patients 52 phase IIb clinical 52 Presents Positive 52 confidence interval #.#-#.# 52 cells/mm3 52 platelet reactivity 52 Phase 1b 51 HCV genotype 51 Arch Intern Med 51 μmol L 51 cabazitaxel 51 EGFR expressing mCRC 51 annualized relapse 51 mg BID 51 prespecified 51 liver metastases 51 Engerix B 51 HRPC 51 mucosal healing